High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia.
Marquis M, Beaubois C, Lavallée VP, Abrahamowicz M, Danieli C, Lemieux S, Ahmad I, Wei A, Ting SB, Fleming S, Schwarer A, Grimwade D, Grey W, Hills RK, Vyas P, Russell N, Sauvageau G, Hébert J.
Marquis M, et al. Among authors: grey w.
Blood Cancer J. 2018 Jul 19;8(8):68. doi: 10.1038/s41408-018-0103-6.
Blood Cancer J. 2018.
PMID: 30061630
Free PMC article.